About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [269 citations: 1–100 of 255 articles]

Articles published in Prostate Cancer have been cited 269 times. The following is a list of the 255 articles that have cited the articles published in Prostate Cancer.

  • G. A. Gomez, R. Lopez-Cubillana, and P. Lopez, “Is minimally invasive transanal surgery an alternative for rectal-urinary f istula correction?,” Actas Urologicas Espanolas, vol. 38, no. 4, pp. 276–277, 2014. View at Publisher · View at Google Scholar
  • Rose G. Radin, Shiriki K. Kumanyika, Edward A. Ruiz-Narvaez, Julie R. Palmer, and Lynn Rosenberg, “Prospective study of dietary fat and risk of uterine leiomyomata,” American Journal of Clinical Nutrition, vol. 99, no. 5, pp. 1105–1116, 2014. View at Publisher · View at Google Scholar
  • Nathan A. Berger, “Obesity and cancer pathogenesis,” Annals of the New York Academy of Sciences, vol. 1311, no. 1, pp. 57–76, 2014. View at Publisher · View at Google Scholar
  • Anna Ida Fiaschi, Roberto Petrioli, Filippo Francini, Vincenzo Bianco, Armando Perrella, Giovanni Paganini, Letizia Laera, and Giandomenico Roviello, “Abiraterone in heavily pretreated patients with metastatic castrate-resista nt prostate cancer,” Anti-Cancer Drugs, vol. 25, no. 4, pp. 472–477, 2014. View at Publisher · View at Google Scholar
  • Katsura Kakoki, Haruka Kamiyama, Mai Izumida, Yuka Yashima, Hideki Hayashi, Naoki Yamamoto, Toshifumi Matsuyama, Tsukasa Igawa, Hideki Sakai, and Yoshinao Kubo, “Androgen-independent proliferation of LNCaP prostate cancer cells infected by xenotropic murine leukemia virus-related virus,” Biochemical and Biophysical Research Communications, 2014. View at Publisher · View at Google Scholar
  • Adam M. Hirst, Fiona M. Frame, Norman J. Maitland, and Deborah O’Connell, “Low Temperature Plasma: A Novel Focal Therapy for Localized Prostate Cancer?,” BioMed Research International, vol. 2014, pp. 1–15, 2014. View at Publisher · View at Google Scholar
  • Jan Tykvart, Jiří Schimer, Jitka Bařinková, Petr Pachl, Lenka Poštová-Slavětínská, Pavel Majer, Jan Konvalinka, and Pavel Šácha, “Rational design of urea-based glutamate carboxypeptidase II (GCPII) inhibitors as versatile tools for specific drug targeting and delivery,” Bioorganic & Medicinal Chemistry, 2014. View at Publisher · View at Google Scholar
  • Andrea R. Spence, Marie-Claude Rousseau, Pierre I. Karakiewicz, and Marie-Élise Parent, “Circumcision and prostate cancer: a population-based case-control study in Montréal, Canada,” BJU International, 2014. View at Publisher · View at Google Scholar
  • Ying Zhang, Thomas Perez, Beth Blondin, Jing Du, Ping Liu, Diana Escarzaga, John S. Coon, and Larry E. Morrison, “Identification of FISH biomarkers to detect chromosome abnormalities associ ated with prostate adenocarcinoma in tumour and field effect environment,” Bmc Cancer, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Brandon A. Mahal, David R. Ziehr, Andrew S. Hyatt, Emily H. Neubauer-Sugar, Desmond A. O'Farrell, Michael P. O'Leary, Graeme S. Steele, Thomas R. Niedermayr, Clair J. Beard, Neil E. Martin, Peter F. Orio, Anthony V. D'Amico, Phillip M. Devlin, and Paul L. Nguyen, “Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term results,” Brachytherapy, 2014. View at Publisher · View at Google Scholar
  • A Paziewska, M Dabrowska, K Goryca, A Antoniewicz, J Dobruch, M Mikula, D Jarosz, L Zapala, A Borowka, and J Ostrowski, “DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy,” British Journal of Cancer, 2014. View at Publisher · View at Google Scholar
  • M Shipitsin, C Small, S Choudhury, E Giladi, S Friedlander, J Nardone, S Hussain, A D Hurley, C Ernst, Y E Huang, H Chang, T P Nifong, D L Rimm, J Dunyak, M Loda, D M Berman, and P Blume-Jensen, “Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error,” British Journal of Cancer, 2014. View at Publisher · View at Google Scholar
  • Elizabeth J. Davis, Jennifer L. Beebe-Dimmer, Cecilia L. Yee, and Kathleen A. Cooney, “Risk of second primary tumors in men diagnosed with prostate cancer: A population-based cohort study,” Cancer, 2014. View at Publisher · View at Google Scholar
  • Lei Chang, Peter H. Graham, Jingli Hao, Joseph Bucci, Paul J. Cozzi, John H. Kearsley, and Yong Li, “Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy,” Cancer and Metastasis Reviews, 2014. View at Publisher · View at Google Scholar
  • Caryn E. Peterson, Garth H. Rauscher, Timothy P. Johnson, Carolyn V. Kirschner, Richard E. Barrett, Seijeoung Kim, Marian L. Fitzgibbon, Charlotte E. Joslin, and Faith G. Davis, “The association between neighborhood socioeconomic status and ovarian cancer tumor characteristics,” Cancer Causes & Control, 2014. View at Publisher · View at Google Scholar
  • Ramogomo Frans Matshela, Johanna E. Maree, and Corrien van Belkum, “Prevention and Detection of Prostate Cancer,” Cancer Nursing, vol. 37, no. 3, pp. 189–197, 2014. View at Publisher · View at Google Scholar
  • G. Liu, D. Shen, L. Jiao, and Y. Sun, “Nin one binding protein expression as a prognostic marker in prostate carcinoma,” Clinical and Translational Oncology, 2014. View at Publisher · View at Google Scholar
  • Masaki Shiota, Ario Takeuchi, Kenjiro Imada, Eiji Kashiwagi, YooHyun Song, Junichi Inokuchi, Katsunori Tatsugami, Takeshi Uchiumi, and Seiji Naito, “Inhibition of Protein Kinase C/Twist1 Signaling Augments Anticancer Effects of Androgen Deprivation and Enzalutamide in Prostate Cancer,” Clinical Cancer Research, vol. 20, no. 4, pp. 951–961, 2014. View at Publisher · View at Google Scholar
  • Alexander E. Rand, Ankit Agarwal, Divya Ahuja, Taylor Ngo, Muhammad M. Qureshi, Apar Gupta, and Ariel E. Hirsch, “Patient demographics and disease stage as drivers of disparities in mortality in prostate cancer patients receiving care at a safety net academic medical center,” Clinical Genitourinary Cancer, 2014. View at Publisher · View at Google Scholar
  • A.C. Tree, V.S. Khoo, N.J. van As, and M. Partridge, “Is Biochemical Relapse-free Survival After Profoundly Hypofractionated Radiotherapy Consistent with Current Radiobiological Models?,” Clinical Oncology, 2014. View at Publisher · View at Google Scholar
  • C Grenade, M A Phelps, and M A Villalona-Calero, “Race and Ethnicity in Cancer Therapy: What Have We Learned?,” Clinical Pharmacology & Therapeutics, 2014. View at Publisher · View at Google Scholar
  • Bernhard Ralla, Carsten Stephan, Sebastian Meller, Dimo Dietrich, Glen Kristiansen, and Klaus Jung, “Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies*,” Critical Reviews in Clinical Laboratory Sciences, pp. 1–32, 2014. View at Publisher · View at Google Scholar
  • Edward Ottley, and Elspeth Gold, “microRNA and non-canonical TGF-βsignalling: implications for prostate cancer therapy,” Critical Reviews in Oncology/Hematology, 2014. View at Publisher · View at Google Scholar
  • Philip C. Calder, and Richard J. Deckelbaum, “Dietary fatty acids in health and disease,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 17, no. 2, pp. 111–115, 2014. View at Publisher · View at Google Scholar
  • C. Mary Schooling, “Testosterone and cardiovascular disease,” Current Opinion in Endocrinology & Diabetes and Obesity, vol. 21, no. 3, pp. 202–208, 2014. View at Publisher · View at Google Scholar
  • Ulka Vaishampayan, “Therapeutic options and multifaceted treatment paradigms in metastatic castrate-resistant prostate cancer,” Current Opinion in Oncology, vol. 26, no. 3, pp. 265–273, 2014. View at Publisher · View at Google Scholar
  • Michael J. Solomon, Ker-Kan Tan, Richard Gideon Bromilow, and James C. H. Wong, “Bilateral Puborectalis Interposition Repair of Rectourethral Fistula,” Diseases of the Colon & Rectum, vol. 57, no. 1, pp. 133–139, 2014. View at Publisher · View at Google Scholar
  • Matt Shirley, and Paul L. McCormack, “Radium-223 Dichloride: A Review of Its Use in Patients with Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases,” Drugs, 2014. View at Publisher · View at Google Scholar
  • Lin Wang, and Suling Li, “Effect of Resistant Starch as Dietary Fiber Substitute on Cookies Quality E valuation,” Food Science and Technology Research, vol. 20, no. 2, pp. 263–272, 2014. View at Publisher · View at Google Scholar
  • Sankar N Krishna, and Raymond C Bergan, “Therapeutic modulation of prostate cancer metastasis,” Future Medicinal Chemistry, vol. 6, no. 2, pp. 223–239, 2014. View at Publisher · View at Google Scholar
  • Julio Fernandez-Banet, Nikki P. Lee, Kin Tak Chan, Huan Gao, Xiao Liu, Wing Kin Sung, Winnie Tan, Sheung Tat Fan, Ronnie T. Poon, Shiyong Li, Keith Ching, Paul Rejto, Mao Mao, and Zhengyan Kan, “Decoding Complex Patterns of Genomic Rearrangement in Hepatocellular Carcinoma,” Genomics, 2014. View at Publisher · View at Google Scholar
  • Marci J Clark, Nimanee Harris, Ingolf Griebsch, Dagmar Kaschinski, and Catherine Copley-Merriman, “Patient-reported outcome labeling claims and measurement approach for metastatic castration-resistant prostate cancer treatments in the United States and European Union,” Health and Quality of Life Outcomes, vol. 12, no. 1, pp. 104, 2014. View at Publisher · View at Google Scholar
  • Madhuwanti Srinivasan, Souresh Banerjee, Allison Palmer, Guoxing Zheng, Aoshuang Chen, Maarten C. Bosland, André Kajdacsy-Balla, Ramaswamy Kalyanasundaram, and Gnanasekar Munirathinam, “HMGB1 in Hormone-Related Cancer: a Potential Therapeutic Target,” Hormones and Cancer, 2014. View at Publisher · View at Google Scholar
  • Kathleen C. Torkko, R. Storey Wilson, M. Scott Lucia, and David G. Bostwick, “Prostatic atrophy: its spatial proximity to carcinoma and intraepithelial n eoplasia based on annotation of digital slides,” Human Pathology, vol. 45, no. 1, pp. 54–58, 2014. View at Publisher · View at Google Scholar
  • Jie Liu, Shuai Hu, Yun Cui, Meng-Kui Sun, Feng Xie, and Qian Zhang, “Saturated Fatty Acids Up-regulate COX-2 Expression in Prostate Epithelial C ells via Toll-like Receptor 4/NF-kappa B Signaling,” Inflammation, vol. 37, no. 2, pp. 467–477, 2014. View at Publisher · View at Google Scholar
  • Yongqiang Chen, Lu Zheng, Junquan Liu, Zhonghai Zhou, Xiliang Cao, Xiaoting Lv, and Fuxing Chen, “Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways,” International Immunopharmacology, 2014. View at Publisher · View at Google Scholar
  • Bregje van Oorschot, Suzanne E. Hovingh, Perry D. Moerland, Jan Paul Medema, Lukas J.A. Stalpers, Harry Vrieling, and Nicolaas A.P. Franken, “Reduced Activity of Double-Strand Break Repair Genes in Prostate Cancer Patients With Late Normal Tissue Radiation Toxicity,” International Journal of Radiation Oncology*Biology*Physics, 2014. View at Publisher · View at Google Scholar
  • Dietmar Georg, Johannes Hopfgartner, Joanna Gòra, Peter Kuess, Gabriele Kragl, Daniel Berger, Neamat Hegazy, Gregor Goldner, and Petra Georg, “Dosimetric Considerations to Determine the Optimal Technique for Localized Prostate Cancer Among External Photon, Proton, or Carbon-Ion Therapy and High-Dose-Rate or Low-Dose-Rate Brachytherapy,” International Journal of Radiation Oncology*Biology*Physics, vol. 88, no. 3, pp. 715–722, 2014. View at Publisher · View at Google Scholar
  • Hyeyeol Bae, Yoh Matsuoka, Hiroshi Nakajima, Eisaku Ito, Hiroshi Tanaka, Miyako Oya, Takayuki Nakayama, Hideki Takeshita, Toshiki Kijima, Junichiro Ishioka, Noboru Numao, Fumitaka Koga, Kazutaka Saito, Takumi Akashi, Yasuhisa Fujii, and Kazunori Kihara, “Apparent diffusion coefficient value as a biomarker reflecting morphologica l and biological features of prostate cancer,” International Urology and Nephrology, vol. 46, no. 3, pp. 555–561, 2014. View at Publisher · View at Google Scholar
  • Daniel A. Hamstra, “RE: Mortality After Radical Prostatectomy or External Beam Radiotherapy for Localized Prostate Cancer,” Jnci-Journal of The National Cancer Institute, vol. 106, no. 3, 2014. View at Publisher · View at Google Scholar
  • Jing Li, Chunquan Li, Junwei Han, Chunlong Zhang, Desi Shang, Qianlan Yao, Yunpeng Zhang, Yanjun Xu, Wei Liu, Meng Zhou, Haixiu Yang, Fei Su, and Xia Li, “The detection of risk pathways, regulated by miRNAs, via the integration of sample-matched miRNA-mRNA profiles and pathway structure,” Journal of Biomedical Informatics, 2014. View at Publisher · View at Google Scholar
  • Timothe Kambou, Barnabe Zango, and Ali Ouedraogo, “Knowledge and Awareness of Prostate Cancer Among the General Public in Burk ina Faso,” Journal of Cancer Education, vol. 29, no. 1, pp. 69–73, 2014. View at Publisher · View at Google Scholar
  • Nicholas H. Farina, Marie E. Wood, Scott D. Perrapato, Christopher S. Francklyn, Gary S. Stein, Janet L. Stein, and Jane B. Lian, “Standardizing Analysis of Circulating MicroRNA: Clinical and Biological Relevance,” Journal of Cellular Biochemistry, vol. 115, no. 5, pp. 805–811, 2014. View at Publisher · View at Google Scholar
  • G. Paolo Dotto, “Multifocal epithelial tumors and field cancerization: stroma as a primary determinant,” Journal of Clinical Investigation, vol. 124, no. 4, pp. 1446–1453, 2014. View at Publisher · View at Google Scholar
  • Nathan S. Consedine, Natalie L. Tuck, Camille R. Ragin, and Benjamin A. Spencer, “Beyond the Black Box: A Systematic Review of Breast, Prostate, Colorectal, and Cervical Screening Among Native and Immigrant African-Descent Caribbean Populations,” Journal of Immigrant and Minority Health, 2014. View at Publisher · View at Google Scholar
  • Y. Mao, I. Poschke, and R. Kiessling, “Tumour-induced immune suppression: role of inflammatory mediators released by myelomonocytic cells,” Journal of Internal Medicine, 2014. View at Publisher · View at Google Scholar
  • Ali Serdar Gözen, Yigit Akin, Murat Akgul, Cenk Yazici, Jan Klein, and Jens Rassweiler, “A Novel Practical Trocar Placement Technique for Extraperitoneal Laparoscopic and Robotic-Assisted Laparoscopic Radical Prostatectomy in Patients with Lower Midline Abdominal Incisions,” Journal of Laparoendoscopic & Advanced Surgical Techniques, pp. 140430064930005, 2014. View at Publisher · View at Google Scholar
  • Marco Oderda, Xavier Bonet, Davide Campobasso, and Richard Gaston, “Robotic Rectovesical Fistula Repair: A Successful Approach,” Journal of Laparoendoscopic & Advanced Surgical Techniques, vol. 24, no. 8, pp. 567–570, 2014. View at Publisher · View at Google Scholar
  • Paul M. Levine, Michael J. Garabedian, and Kent Kirshenbaum, “Targeting the Androgen Receptor with Steroid Conjugates,” Journal of Medicinal Chemistry, pp. 140708123537006, 2014. View at Publisher · View at Google Scholar
  • Michael P. Hoeh, “PSA Screening: A Discussion Based on the USPSTF Recommendations and the AUA and EAU Guidelines,” Journal of Mens Health, vol. 11, no. 1, pp. 10–17, 2014. View at Publisher · View at Google Scholar
  • Kristina Nilsson, Andreas K. Johansson, Anders Montelius, Ingela Turesson, Risto O. Heikkinen, Gunilla Ljung, and Ulf Isacsson, “Decreasing the Dose to the Rectal Wall by Using a Rectal Retractor during Radiotherapy of Prostate Cancer: A Comparative Treatment Planning Study,” Journal of Radiotherapy, vol. 2014, pp. 1–7, 2014. View at Publisher · View at Google Scholar
  • Masaki Shiota, Akira Yokomizo, Ario Takeuchi, Kenjiro Imada, Keijiro Kiyoshima, Junichi Inokuchi, Katsunori Tatsugami, and Seiji Naito, “The feature of metabolic syndrome is a risk factor for biochemical recurrence after radical prostatectomy,” Journal of Surgical Oncology, 2014. View at Publisher · View at Google Scholar
  • Sofia Nahavandi, Sara Baratchi, Rebecca Soffe, Shi-Yang Tang, Saeid Nahavandi, Arnan Mitchell, and Khashayar Khoshmanesh, “Microfluidic platforms for biomarker analysis,” Lab on a Chip, vol. 14, no. 9, pp. 1496, 2014. View at Publisher · View at Google Scholar
  • Tharindu De Silva, Derek W. Cool, Cesare Romagnoli, Aaron Fenster, and Aaron D. Ward, “Evaluating the utility of intraprocedural 3D TRUS image information in guiding registration for displacement compensation during prostate biopsy,” Medical Physics, vol. 41, no. 8, pp. 082901, 2014. View at Publisher · View at Google Scholar
  • Isaac Adewole, Damali N. Martin, Makeda J. Williams, Clement Adebamowo, Kishor Bhatia, Christine Berling, Corey Casper, Karima Elshamy, Ahmed Elzawawy, Rita T. Lawlor, Rosa Legood, Sam M. Mbulaiteye, Folakemi T. Odedina, Olufunmilayo I. Olopade, Christopher O. Olopade, Donald M. Parkin, Timothy R. Rebbeck, Hana Ross, Luiz A. Santini, Julie Torode, Edward L. Trimble, Christopher P. Wild, Annie M. Young, and David J. Kerr, “Building capacity for sustainable research programmes for cancer in Africa,” Nature Reviews Clinical Oncology, 2014. View at Publisher · View at Google Scholar
  • Albert J. Chang, Karen A. Autio, Mack Roach, and Howard I. Scher, “High-risk prostate cancer—classification and therapy,” Nature Reviews Clinical Oncology, 2014. View at Publisher · View at Google Scholar
  • Xiaodong Sun, Xiaoying Fu, Jie Li, Changsheng Xing, Henry F. Frierson, Hao Wu, Xiaokun Ding, Tongzhong Ju, Richard D. Cummings, and Jin-Tang Dong, “Deletion of Atbf1/Zfhx3 In Mouse Prostate Causes Neoplastic Lesions, Likely by Attenuation of Membrane and Secretory Proteins and Multiple Signaling Pathways,” Neoplasia, 2014. View at Publisher · View at Google Scholar
  • Matthew K. H. Hong, Geoff Macintyre, Heather Lewis, Adam Kowalczyk, Anthony J. Costello, Niall M. Corcoran, and Christopher M. Hovens, “Curated MicroRNAs in Urine and Blood Fail to Validate as Predictive Biomark ers for High-Risk Prostate Cancer,” Plos One, vol. 9, no. 4, 2014. View at Publisher · View at Google Scholar
  • Zy Yu Zheng-Yuan, Yl Song Ya-Li, Zj Gong Zhao-Jian, Zy Zeng Zhao-Yang, Jh Lu Jian-Hong, Xl Li Xiao-Ling, and Gy Li Gui-Yuan, “The Mechanism and Tumorigenesis of Oncogenic DNA Virus Integration,” Progress in Biochemistry and Biophysics, vol. 41, no. 4, pp. 324–331, 2014. View at Publisher · View at Google Scholar
  • Ksenija Limani, Fouad Aoun, Serge Holz, Marianne Paesmans, Alexandre Peltier, and Roland van Velthoven, “Single High Intensity Focused Ultrasound Session as a Whole Gland Primary Treatment for Clinically Localized Prostate Cancer: 10-Year Outcomes,” Prostate Cancer, vol. 2014, pp. 1–7, 2014. View at Publisher · View at Google Scholar
  • Chantal Babb, Margaret Urban, Danuta Kielkowski, and Patricia Kellett, “Prostate Cancer in South Africa: Pathology Based National Cancer Registry Data (1986–2006) and Mortality Rates (1997–2009),” Prostate Cancer, vol. 2014, pp. 1–9, 2014. View at Publisher · View at Google Scholar
  • Anthony S. Perry, Bungo Furusato, Raymond B. Nagle, and Sourav Ghosh, “Increased aPKC Expression Correlates with Prostatic Adenocarcinoma Gleason Score and Tumor Stage in the Japanese Population,” Prostate Cancer, vol. 2014, pp. 1–5, 2014. View at Publisher · View at Google Scholar
  • P Sargos, L Ferretti, M Gross-Goupil, M Orre, F Cornelis, B Henriques de Figueiredo, N Houédé, C Merino, G Roubaud, B Dallaudiére, P Richaud, and A Fléchon, “Characterization of prostate neuroendocrine cancers and therapeutic management: a literature review,” Prostate Cancer and Prostatic Disease, 2014. View at Publisher · View at Google Scholar
  • Pagona Roussi, John Scarpato, Kuang-Yi Wen, Fang Zhu, and Gem Roy, “Randomized trial of print messaging: the role of the partner and monitoring style in promoting provider discussions about prostate cancer screening am ong African American men,” Psycho-Oncology, vol. 23, no. 4, pp. 404–411, 2014. View at Publisher · View at Google Scholar
  • Filippo Ammazzalorso, Sebastian Graef, Uli Weber, Andrea Wittig, Rita Engenhart-Cabillic, and Urszula Jelen, “Dosimetric consequences of intrafraction prostate motion in scanned ion beam radiotherapy,” Radiotherapy and Oncology, 2014. View at Publisher · View at Google Scholar
  • Kanerva Lahdensuo, Tuomas Mirtti, Anssi Petas, and Antti Rannikko, “Performance of transrectal prostate biopsies in detecting tumours and implications for focal therapy,” Scandinavian Journal of Urology, pp. 1–7, 2014. View at Publisher · View at Google Scholar
  • Zhu Mei, HuiKe Jiao, Wei Wang, Jie Li, GuoQiang Chen, and Ying Xu, “Polycomb chromobox 4 enhances migration and pulmonary metastasis of hepatocellular carcinoma cell line MHCC97L,” Science China Life Sciences, 2014. View at Publisher · View at Google Scholar
  • Zeta Tak For Yu, Koh Meng Aw Yong, and Jianping Fu, “Microfluidic Blood Cell Sorting: Now and Beyond,” Small, 2014. View at Publisher · View at Google Scholar
  • Edward Vitkin, Amir Ben-Dor, Michael Shmoish, Michaela F. Hartmann, Zohar Yakhini, Stefan A. Wudy, and Ze’ev Hochberg, “Peer Group Normalization and Urine to Blood Context in Steroid Metabolomics: the Case of CAH and Obesity,” Steroids, 2014. View at Publisher · View at Google Scholar
  • Ann W. Hsing, Edward Yeboah, Richard Biritwum, Yao Tettey, Angelo M. De Marzo, Andrew Adjei, George J. Netto, Kai Yu, Yan Li, Anand P. Chokkalingam, Lisa W. Chu, David Chia, Alan Partin, Ian M. Thompson, Sabah M. Quraishi, Shelley Niwa, Robert Tarone, and Robert N. Hoover, “High Prevalence of Screen Detected Prostate Cancer in West Africans: Implications for Racial Disparity of Prostate Cancer,” The Journal of Urology, 2014. View at Publisher · View at Google Scholar
  • Berat Cem Özgür, Ersin Köseoğlu, Ali İhsan Arık, Haşmet Sarıcı, Övünç Bilgin, Cem Nedim Yücetürk, Elif Özer, Eşref Oğuz Güven, Onur Telli, Ali Atan, and Muzaffer Eroğlu, “Synchronous bladder and prostate cancers in the specimens of radical cystoprostatectomy: A multicenter retrospective analysis,” The Kaohsiung Journal of Medical Sciences, 2014. View at Publisher · View at Google Scholar
  • Elizabeth A. Tindall, L. Richard Monare, Desiree C. Petersen, Smit van Zyl, Rae-Anne Hardie, Alpheus M. Segone, Philip A. Venter, M.S. Riana Bornman, and Vanessa M. Hayes, “Clinical presentation of prostate cancer in Black South Africans,” The Prostate, 2014. View at Publisher · View at Google Scholar
  • Masaki Shiota, Akira Yokomizo, Ario Takeuchi, Momoe Itsumi, Kenjiro Imada, Eiji Kashiwagi, Junichi Inokuchi, Katsunori Tatsugami, Takeshi Uchiumi, and Seiji Naito, “Inhibition of RSK/YB-1 signaling enhances the anti-cancer effect of enzalutamide in prostate cancer,” The Prostate, 2014. View at Publisher · View at Google Scholar
  • Nadia Ashour, Javier C. Angulo, Guillermo Andrés, Raúl Alelú, Ana González-Corpas, María V. Toledo, José M. Rodríguez-Barbero, Jose I. López, Manuel Sánchez-Chapado, and Santiago Ropero, “A DNA hypermethylation profile reveals new potential biomarkers for prostate cancer diagnosis and prognosis,” The Prostate, 2014. View at Publisher · View at Google Scholar
  • Petra Hudler, Nina Kocevar, and Radovan Komel, “Proteomic Approaches in Biomarker Discovery: New Perspectives in Cancer Diagnostics,” The Scientific World Journal, vol. 2014, pp. 1–18, 2014. View at Publisher · View at Google Scholar
  • Anna Supernat, Sylwia Łapińska-Szumczyk, Hanna Majewska, Jacek Gulczyński, Wojciech Biernat, Dariusz Wydra, and Anna J. Żaczek, “Tumor Heterogeneity at Protein Level as an Independent Prognostic Factor in Endometrial Cancer,” Translational Oncology, 2014. View at Publisher · View at Google Scholar
  • Erik H. Knelson, Jasmine C. Nee, and Gerard C. Blobe, “Heparan sulfate signaling in cancer,” Trends in Biochemical Sciences, 2014. View at Publisher · View at Google Scholar
  • Juliana Inês Santos, Ana Luísa Teixeira, Francisca Dias, Mónica Gomes, Augusto Nogueira, Joana Assis, and Rui Medeiros, “Restoring TGFβ1 pathway-related microRNAs: possible impact in metastatic prostate cancer development,” Tumor Biology, 2014. View at Publisher · View at Google Scholar
  • Xiao-Feng He, Zhi-Zhong Liu, Jian-Jun Xie, Wei Wang, Ya-Ping Du, Yu Chen, and Wu Wei, “Association between the CYP3A4 and CYP3A5 polymorphisms and cancer risk: a meta-analysis and meta-regression,” Tumor Biology, 2014. View at Publisher · View at Google Scholar
  • James M. Jamison, Deborah Neal, and Jack L. Summers, “Synergistic Antitumor Cytotoxic Actions of Ascorbate and Menadione on Human Prostate (DU145) Cancer Cells In Vitro: Nucleus and Other Injuries Precedi ng Cell Death by Autoschizis,” Ultrastructural Pathology, vol. 38, no. 2, pp. 116–140, 2014. View at Publisher · View at Google Scholar
  • Monique J. Roobol, “International Perspectives on Screening,” Urologic Clinics of North America, vol. 41, no. 2, pp. 237–247, 2014. View at Publisher · View at Google Scholar
  • Huan Ding, Ying Sun, Yu Hou, and Li Li, “Effects of INPP4B gene transfection combined with PARP inhibitor on castration therapy—Resistant prostate cancer cell line, PC3,” Urologic Oncology: Seminars and Original Investigations, 2014. View at Publisher · View at Google Scholar
  • Brandon A. Mahal, David R. Ziehr, Ayal A. Aizer, Andrew S. Hyatt, Jesse D. Sammon, Marianne Schmid, Toni K. Choueiri, Jim C. Hu, Christopher J. Sweeney, Clair J. Beard, Anthony V. D׳Amico, Neil E. Martin, Christopher Lathan, Simon P. Kim, Quoc-Dien Trinh, and Paul L. Nguyen, “Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer,” Urologic Oncology: Seminars and Original Investigations, 2014. View at Publisher · View at Google Scholar
  • Dae-Seon Yoo, Seung Hyo Woo, Seok Cho, Seok Ho Kang, Sang Jin Kim, Sung Yul Park, Sang Hyub Lee, Seung Hyun Jeon, and Jinsung Park, “Practice Patterns of Urologists in Managing Korean Men Aged 40 Years or Younger With High Serum Prostate-specific Antigen Levels,” Urology, 2014. View at Publisher · View at Google Scholar
  • Brandon A. Mahal, Michael P. O'Leary, and Paul L. Nguyen, “Hydrogel Spacing for Radiotherapy of Prostate Cancer: A Review of the Literature,” Urology Practice, 2014. View at Publisher · View at Google Scholar
  • Sebastian Piotrowicz, Michal Skrzypczyk, Tomasz Golabek, Piotr Chlosta, and Andrzej Borowka, “Clinical value of extended pelvic lymph node dissection in patients subject ed to radical prostatectomy,” Videosurgery and Other Miniinvasive Techniques, vol. 9, no. 1, pp. 64–70, 2014. View at Publisher · View at Google Scholar
  • Adam D. Toll, “Urinary Cytomorphology and Clinical Correlates of Prostatic Small Cell Neur oendocrine Carcinoma,” Acta Cytologica, vol. 57, no. 5, pp. 495–500, 2013. View at Publisher · View at Google Scholar
  • Anna Pettersson, Ingela Turesson, Christina Persson, and Birgitta Johansson, “Assessing patients’ perceived bother from the gastrointestinal side effects of radiotherapy for localized prostate cancer: Initial questionnaire development and validation,” Acta Oncologica, pp. 1–10, 2013. View at Publisher · View at Google Scholar
  • Kevin Krughoff, Khadijah Eid, Jason Phillips, Diliana Stoimenova, Daniel Smith, Colin O’Donnell, E. David Crawford, and Al Barqawi, “The Accuracy of Prostate Cancer Localization Diagnosed on Transrectal Ultrasound-Guided Biopsy Compared to 3-Dimensional Transperineal Approach,” Advances in Urology, vol. 2013, pp. 1–5, 2013. View at Publisher · View at Google Scholar
  • H. S. Park, J. D. Schoenfeld, R. B. Mailhot, M. Shive, R. I. Hartman, R. Ogembo, and L. A. Mucci, “Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis,” Annals of Oncology, 2013. View at Publisher · View at Google Scholar
  • Tanya I. Stoyanova, and Andrew S. Goldstein, “Identification, characterization and targeting of Docetaxel-resistant prost ate cancer cells,” Asian Journal of Andrology, vol. 15, no. 1, pp. 83–84, 2013. View at Publisher · View at Google Scholar
  • Yun-Fei Li, Shao-Feng Zhang, Tao-Tao Zhang, Lei Li, Wei Gan, Hong-Tao Jia, Sheng Xie, Hui-Hua Ji, and Da-Lin He, “Intermittent tri-weekly docetaxel plus bicalutamide in patients with castration-resistant prostate cancer: a single-arm prospective study using a historical control for comparison,” Asian Journal of Andrology, 2013. View at Publisher · View at Google Scholar
  • Dong Il Kang, Hong Koo Ha, Kweonsik Min, Jangho Yoon, Wansuk Kim, Won Ik Seo, Pil moon Kang, Soo Jin Jung, and Isaac Yi Kim, “Korean Prostate Cancer Patients Have Worse Disease Characteristics than the ir American Counterparts,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 11, pp. 6913–6917, 2013. View at Publisher · View at Google Scholar
  • Mathis Grossmann, Ada S. Cheung, and Jeffrey D. Zajac, “Androgens and prostate cancer; pathogenesis and deprivation therapy,” Best Practice & Research Clinical Endocrinology & Metabolism, 2013. View at Publisher · View at Google Scholar
  • Jean-Joseph Hoang, Silvère Baron, David H. Volle, Jean-Marc A. Lobaccaro, and Amalia Trousson, “Lipids, LXRs and prostate cancer: Are HDACs a new link?,” Biochemical Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Hai-Dong Yao, Qiong Wu, Zi-Wei Zhang, Shu Li, Xiao-Long Wang, Xin-Gen Lei, and Shi-Wen Xu, “Selenoprotein W serves as an antioxidant in chicken myoblasts,” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1830, no. 4, pp. 3112–3120, 2013. View at Publisher · View at Google Scholar
  • Sophie E McGrath, Agnieszka Michael, Richard Morgan, and Hardev Pandha, “EN2: a novel prostate cancer biomarker,” Biomarkers in Medicine, vol. 7, no. 6, pp. 893–901, 2013. View at Publisher · View at Google Scholar
  • Awatef Ben Jemaa, Yosra Bouraoui, Sataa Sallami, Yassine Nouira, and Ridha Oueslati, “A Comparison of the Biological Features of Prostate Cancer with (PSA+, PSMA+) Profile according to RKIP,” BioMed Research International, vol. 2013, pp. 1–7, 2013. View at Publisher · View at Google Scholar
  • M. L. Verschoor, R. Ungard, A. Harbottle, J. P. Jakupciak, R. L. Parr, and G. Singh, “Mitochondria and Cancer: Past, Present, and Future,” Biomed Research International, 2013. View at Publisher · View at Google Scholar
  • Martin Andreas Røder, Klaus Brasso, Ib Jarle Christensen, Jørgen Johansen, Niels Christian Langkilde, Helle Hvarness, Steen Carlsson, Henrik Jakobsen, Michael Borre, and Peter Iversen, “Survival after radical prostatectomy for clinically localised prostate cancer: a population-based study,” BJU International, 2013. View at Publisher · View at Google Scholar